Goode, Ellen L

Positions

• , Peter MacCallum Cancer Centre
• , Roswell Park Cancer Institute
• , Children's Cancer Institute Australia
• , Oregon Health & Science University
• , Mayo Clinic
• , German Cancer Research Center
• , Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De
• , Authors' Affiliations: Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Texas, School of Public Health, Houston, Texas; Queensland Institute of Medical Research, Brisbane, Australia; Peter MacCallum Cancer Centre, East Melbourne, Australia; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Departments of Health Sciences Research and Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Community and Family Medicine, Obstetrics and Gynecology, and Statistical Science, Duke University; Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; Departments of Gynecology, Epidemiology, Biostatistics and HTA, and Urology, Radboud University Medical Centre, Nijmegen; Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
• , Department of Health Science Research, Division of Epidemiology, Mayo Clinic, 200 First Street SW, Charlton 6, 55905, Rochester, MN, USA
• , Department of Health Science Research, Division of Epidemiology, Mayo Clinic, 200 First Street SW, Charlton 6, Rochester, MN, USA
• , Department of Health Science Research, Division of Epidemiology Mayo Clinic Rochester MN
• , Health Sciences Research, Division of Epidemiology;
• , Honglin Song, Ed Dicks, Jonathan P. Tyrer, Patricia Harrington, Jennifer Alsop, and Paul D.P. Pharoah, University of Cambridge; Mercedes Jimenez-Linan, Addenbrooke's Hospital, Cambridge; Jane Hayward, Lindsay Fraser, Susan Philpott, Christopher Anderson, Adam Rosenthal, Aleksandra Gentry-Maharaj, Usha Menon, and Ian J. Jacobs, University College London; David D. Bowtell, Imperial College London, London; Ian J. Jacobs, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom; Susan J. Ramus, Maria P. Intermaggio, Christopher K. Edlund, David Conti, and Simon A. Gayther, University of Southern California, Los Angeles, CA; David D. Bowtell and Kathryn Alsop, Peter MacCallum Cancer Centre, East Melbourne; David D. Bowtell, University of Melbourne, Melbourne, Victoria, Australia; Mine S. Cicek, Julie M. Cunningham, and Ellen L. Goode, Mayo Clinic, Rochester, MN; Brooke L. Fridley, University of Kansas Medical Center, Kansas City, KS; Estrid Høgdall, Allan Jensen, and Susanne Krüger, Danish Cancer Society Research Center; Estrid Høgdall, Herlev Hospital, University of Copenhagen; Claus K. Høgdall and Susanne Krüger, Rigshospitalet, Copenhagen, Denmark; Jan Lubiński, Tomasz Huzarski, Anna Jakubowska, and Jacek Gronwald, Pomeranian Medical University, Szczecin, Poland; and Samantha Poblete, Shashi Lele, Lara Sucheston-Campbell, Kirsten B. Moysich, and Kunle Odunsi, Roswell Park Cancer Institute, Buffalo, NY.
• , Mayo Clinic, SW Rochester, MN, USA.
• , Mayo Clinic Department of Health Science Research, Division of Epidemiology Rochester Minnesota United States of America
• , Mayo Clinic Department of Health Sciences Research, Division of Epidemiology Rochester MN USA